Promising Results of Phase 3 Trial for Cabozantinib and Atezolizumab Combination in Metastatic CastrationResistant Prostate Cancer
On January 25, 2024, Exelixis, Inc. unveiled the detailed outcomes of the phase 3 pivotal study CONTACT-02. This study focused ...
